Aetna Inc. (AET)

204.27
0.93 0.45
NYSE : Health Services
Prev Close 205.20
Open 205.66
Day Low/High 203.70 / 206.00
52 Wk Low/High 149.69 / 206.66
Volume 4.88M
Avg Volume 1.81M
Exchange NYSE
Shares Outstanding 327.10M
Market Cap 67.27B
EPS 5.70
P/E Ratio 19.40
Div & Yield 2.00 (0.97%)
Future Media Deals In Peril With DOJ AT&T Challenge; Hain Suitors Aplenty--ICYMI

Future Media Deals In Peril With DOJ AT&T Challenge; Hain Suitors Aplenty--ICYMI

Here's what you need to know for Tuesday, Nov. 21

A CVS-Aetna Merger Could Make You Rich

A CVS-Aetna Merger Could Make You Rich

CVS is showing red flags as investors mull Aetna acquisition.

CVS-Aetna Tie-Up Likely to Pass Regulatory Scrutiny

CVS-Aetna Tie-Up Likely to Pass Regulatory Scrutiny

The pharmacy chain could arrive at a deal to acquire the health insurer for more than $66 billion by the end of the month.

McDonald's, Ultra Clean Holdings, Aetna: 'Mad Money' Lightning Round

McDonald's, Ultra Clean Holdings, Aetna: 'Mad Money' Lightning Round

Jim Cramer is bullish on McDonald's, Ultra Clean Holdings, Aetna, Baozun and more.

Breaking Down This Downturn: Cramer's 'Mad Money' Recap (Tuesday, 11/14/17)

Breaking Down This Downturn: Cramer's 'Mad Money' Recap (Tuesday, 11/14/17)

Jim Cramer analyzes the reasons investors should be worried, and more important, why this is the pullback that presents buying opportunities.

Healthcare Stocks Mixed as Initial Obamacare Enrollment Higher Than Last Year

Healthcare Stocks Mixed as Initial Obamacare Enrollment Higher Than Last Year

More than one in five who signed up for Obamacare open enrollment during its first week were new customers.

Trump's Antitrust Team Sends Mixed Message on M&A

Trump's Antitrust Team Sends Mixed Message on M&A

Mergers reducing an industry's size to four players from five will be OK, while deals involving Chinese buyers face long odds. The jury is still out on vertically integrated deals.

Aetna Introduces New Low-Cost Prescription Drug Plan (PDP)

Aetna Introduces New Low-Cost Prescription Drug Plan (PDP)

Aetna (NYSE: AET) announced the launch of Aetna Medicare Rx® Select (PDP).

Why I Am Making a Big Bet on Healthcare: Former Apple CEO

Why I Am Making a Big Bet on Healthcare: Former Apple CEO

Former Apple CEO John Sculley has made various bets since he left the tech giants years ago. One more recent bet is on healthcare via digitally-minded PBM RxAdvance.

CVS Posts Negative Retail Same-Store Sales, Announces Next-Day Delivery

CVS Posts Negative Retail Same-Store Sales, Announces Next-Day Delivery

The drugstore beat Wall Street estimates in Q3 earnings

Walgreens Better Watch Its Back With Amazon Lurking

Walgreens Better Watch Its Back With Amazon Lurking

A deal with Rite Aid that hasn't performed and pressures from Amazon and CVS are continuing to mount.

CVS-Aetna Deal Could Come as Soon as December: Report

CVS-Aetna Deal Could Come as Soon as December: Report

The pharmacy chain and health insurer are working on sealing a deal north of $70 billion as early as December, Reuters reported.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

All three major U.S. averages closed higher on Friday.

Nasdaq Closes at a Record as Wall Street Seals October Gains

Nasdaq Closes at a Record as Wall Street Seals October Gains

Another rally in the tech sector gives the Nasdaq the energy to close out October with another record on Tuesday.

Aetna Stays Mum on Possible Blockbuster CVS Marriage

Aetna Stays Mum on Possible Blockbuster CVS Marriage

On the heels of a WSJ report on deal discussions between CVS Health and Aetna, executives at Aetna said on an earnings call Tuesday they are not commenting on rumors.

Nasdaq on Track to Finish October With New Record as Tech Rises

Nasdaq on Track to Finish October With New Record as Tech Rises

Stocks are slightly higher as tech gains kept the Nasdaq in the green.

Pfizer Keeps Dow Gains to a Minimum While Tech Stocks Keep Their Rally Alive

Pfizer Keeps Dow Gains to a Minimum While Tech Stocks Keep Their Rally Alive

Stocks are mixed as a surprise selloff in Pfizer shares weigh on the Dow Jones Industrial Average but tech gains keep the Nasdaq in the green.

Stock Futures Suggest a Wall Street Rebound as Fed Meeting Begins

Stock Futures Suggest a Wall Street Rebound as Fed Meeting Begins

Stock futures move higher on Tuesday, setting up for a recovery from losses a day earlier as U.S. central bankers convene for a policy meeting.

On Halloween, Here Are 5 Scary Stock Charts: Market Recon

On Halloween, Here Are 5 Scary Stock Charts: Market Recon

The fundamentals are there, supported by earnings. Let's look at the charts.

Samsung, Apple, Qualcomm and Facebook - 5 Things You Must Know

Samsung, Apple, Qualcomm and Facebook - 5 Things You Must Know

U.S. stock futures are rising on Tuesday, as the Federal Reserve begins a two-day policy meeting.

Aetna Reports Third-Quarter 2017 Results

Aetna Reports Third-Quarter 2017 Results

Aetna (NYSE: AET) announced third-quarter 2017 net income (1) of $838 million, or $2.

CVS Deal to Buy Aetna Spells Disaster

CVS Deal to Buy Aetna Spells Disaster

Despite the fundamental efficiencies of the deal, for CVS, the technical picture looks pretty bad.

The Aetna Foundation Helps Improve The Health Of 25 Communities Nationwide Through More Than $2 Million In Grants

The Aetna Foundation Helps Improve The Health Of 25 Communities Nationwide Through More Than $2 Million In Grants

Approximately 60 percent of a person's life expectancy is driven by factors outside of the doctor's office - our individual behaviors, as well as social and environmental factors 1.

Novartis, Akzo Nobel and Axalta - 5 Things You Must Know Before the Market Opens

Novartis, Akzo Nobel and Axalta - 5 Things You Must Know Before the Market Opens

U.S. stock futures are lower on Monday.

A CVS Deal for Aetna May Need One Thing to Survive Regulators

A CVS Deal for Aetna May Need One Thing to Survive Regulators

An Aetna-CVS deal is likely to draw antitrust scrutiny because of its sheer size, and may require the companies to part with certain Medicare prescription drug contracts.

CVS-Aetna Tie-Up May Require Divestitures to Survive

CVS-Aetna Tie-Up May Require Divestitures to Survive

An Aetna-CVS deal is likely to draw antitrust scrutiny because of its sheer size, and may require the companies to part with certain Medicare prescription drug contracts.

Let the Good Times Roll as Tech Giants Hit All-Time Highs: LIVE MARKETS BLOG

Let the Good Times Roll as Tech Giants Hit All-Time Highs: LIVE MARKETS BLOG

Amazon, Microsoft and Alphabet all reached all-time highs Friday.

Video: Jim Cramer on Amazon, Alphabet, Microsoft, Intel, Apple, Aetna and CVS

Video: Jim Cramer on Amazon, Alphabet, Microsoft, Intel, Apple, Aetna and CVS

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer analyzes Friday's trending stocks.

Watch: Jim Cramer Thinks Regulators Would Approve a CVS-Aetna Deal

Watch: Jim Cramer Thinks Regulators Would Approve a CVS-Aetna Deal

Amid reports that CVS Health is in discussions to purchase health insurance giant Aetna for $66 billion, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer thinks regulators would approve such a deal.

CVS Deal With Aetna, Amazon Drugs: Friday's Top Stories

CVS Deal With Aetna, Amazon Drugs: Friday's Top Stories

Today's top stories: CVS could buy insurance company Aetna, Amazon might get into healthcare, and Google is on track to become the second company to reach a valuation of $700B.

TheStreet Quant Rating: A- (Buy)